Manufacturing

Articles

Sartorius has delivered to ABL’s Strasbourg facility, a GMP viral vector manufacturing package solution that includes single-use bioreactors and an automation platform for normal flow filtration, tangential filtration, and mixing.

Sartorius Supports ABL Europe in Viral Vector GMP Capacity Expansion

The contract development and manufacturing organization has expanded biologics capacity at its facility in Berkeley, CA.

AGC Biologics Expands Biologics Capacity

GlobalData reports the need to shift away from egg-based manufacturing of vaccines in light of influenza-related deaths.

GlobalData Reports Need to Shift to Newer Vaccine Manufacturing Technologies

Under this agreement, the companies will develop in parallel an antibody drug candidate and cell lines for other potential candidates.

ProBioGen and Surface Oncology Sign Second Antibody Manufacturing Program

The contract development and manufacturing organization has entered it first manufacturing contract worth $148 million for its recently completed Plant 3 facility.

Samsung BioLogics Gets $148-Million Contract for New Manufacturing Plant

The new training center, the Jefferson Institute for Bioprocessing, will prepare engineering students and industry professionals for the field of biologics manufacturing.

Jefferson and NIBRT Partner on New Biomanufacturing Training Center

The study suggests that circumventing evolution in cell factories can enable the commercialization of new biobased chemicals to large-scale.

Novo Nordisk Publishes New Study on Bioproduction of Chemicals

Ompi EZ-fill vials and Daikyo Seiko PLASCAP press-fit closures are a confirmed product set for use with Vanrx Pharmasystems' Aseptic Filling Workcells. 

Product Set for Aseptic Filling Workcells

Ferring Pharmaceuticals will expand its biologics capabilities at its headquarters and manufacturing site in Saint-Prex, Switzerland.

Ferring to Invest in New Biotech Center

Unlike current approaches where bioconjugation is typically done following the manufacture of the monoclonal antibody and the cytotoxic drug, the new method begins with the antibody supernatants and eliminates the need for extensive chromatographic purification. 

Manufacturing, Biologic Drugs